We are live on
!
Find out more
HCM
Harspring Capital Management Portfolio holdings
AUM
$190M
1-Year Est. Return
19.3%
This Fund
S&P 500
This Quarter
Est. Return
+2.32%
1 Year Est. Return
+19.3%
3 Year Est. Return
+76.96%
5 Year Est. Return
+46.98%
10 Year Est. Return
–
AUM
$190M
AUM Growth
-$79.5M
(-29%)
Cap. Flow
-$78.4M
Cap. Flow
% of AUM
-41.26%
Top 10 Holdings %
Top 10 Hldgs %
88.41%
Holding
14
New
–
Increased
–
Reduced
14
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Darling Ingredients
DAR
|
+$24.1M |
| 2 |
Enova International
ENVA
|
+$8.27M |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.05M |
| 4 |
Cogent Communications
CCOI
|
+$6.95M |
| 5 |
Amazon
AMZN
|
+$6.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 41.74% |
| 2 | Consumer Staples | 19.62% |
| 3 | Consumer Discretionary | 17.81% |
| 4 | Financials | 17.42% |
| 5 | Industrials | 3.41% |
No holdings matched the selected filter criteria.
Similar funds
RCAP
WSL
CFA
BC
SCM
BCPWM
SF
HVCM
Harspring Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Harspring Capital Management held 14 positions worth $190M, down 29% from $270M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Harspring Capital Management withdrew a net $78.4M in Q1 2026, reducing 14 holdings. Its largest reduction was Darling Ingredients, cutting an estimated $24.1M.
By sector, the portfolio is most concentrated in Communication Services at 42% of assets, down from 42% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
- Harspring Capital Management's biggest Q1 2026 reduction was Darling Ingredients, cutting an estimated $24.1M.
- Harspring Capital Management's ten largest holdings make up 88% of its $190M portfolio in Q1 2026.
- Harspring Capital Management opened 0 new positions and closed 0 in Q1 2026.
- Harspring Capital Management's portfolio value fell 29% quarter-over-quarter to $190M.
Based on Harspring Capital Management's 13F filing for Q1 2026, filed 13 May 2026.